Topic - Moderna

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies. - Source: Wikipedia

Related Stories

Chickens stand in their cages at a farm, in Iowa, Nov. 16, 2009. (AP Photo/Charlie Neibergall, File)

Federal government awards Moderna $176 million in drive for bird-flu shot

By Tom Howell Jr. - The Washington Times

A Moderna Spikevax COVID-19 vaccine is seen at a drugstore in Cypress, Texas, Sept. 20, 2023. On Thursday, Feb. 1, 2024, the Centers for Disease Control and Prevention said the updated COVID-19 vaccine was 54% effective at preventing symptomatic infection in adults. The shot became available last year as a replacement vaccine designed to better protects against more recent COVID variants. (Melissa Phillip/Houston Chronicle via AP, File)

Study of 99 million COVID-vaccinated people finds links to brain, heart problems

By Staff - The Washington Times

FILE - Pharmacist Lena Springmann prepares a Covid-19 vaccination with Pfizer/Biontech vaccine at a vaccination center in Halle, Germany, Monday, Jan. 11, 2021. The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19. (Hendrik Schmidt/dpa via AP, File)

Years of research laid the groundwork for speedy COVID-19 shots

By Lauran Neergaard - Associated Press

Sounding the Covid-19 Alarm Illustration by Greg Groesch/The Washington Times

Now doctors say COVID-19 is like the common cold?

By Joseph Curl

FILE - A Moderna Spikevax COVID-19 vaccine is seen at a drugstore in Cypress, Texas on Wednesday, Sept. 20, 2023. Since the Centers for Disease Control and Prevention signed off on them for ages 6 months and up in September 2023, people seeking the newest COVID-19 vaccine are running into high demand, insurance headaches and supply delays coast to coast. (Melissa Phillip/Houston Chronicle via AP, File)

Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues

By Devi Shastri - Associated Press

A nurse prepares a syringe of a COVID-19 vaccine at an inoculation station in Jackson, Miss., July 19, 2022. U.S. health officials are proposing a simplified approach to COVID-19 vaccinations, which would allow most adults and children to get a once-a-year shot to protect against the mutating virus. The new system unveiled Monday, Jan. 23, 2023 would make COVID-19 inoculations more like the annual flu shot. Americans would no longer have to keep track of how many shots they’ve received or how many months it’s been since their last booster. (AP Photo/Rogelio V. Solis, File)

CDC recommends updated COVID-19 booster shots for all Americans

By Tom Howell Jr. - The Washington Times

Pfizer (left) and Moderna bivalent COVID-19 vaccines are readied for use at a clinic in Richmond, Va., on Nov. 17, 2022. The Food and Drug Administration on Friday, June 16, 2023, told COVID-19 vaccine makers to update fall shots to target the latest omicron strain. (AP Photo/Steve Helber) ** FILE **

FDA approves updated booster shot for COVID-19 ahead of fall campaign

By Tom Howell Jr. - The Washington Times

A man walks by Pfizer headquarters, Friday, Feb. 5, 2021, in New York. (AP Photo/Mark Lennihan, File)

Big Pharma’s outrageous, despicable multibillion-dollar tax dodge

By Cheryl K. Chumley - The Washington Times

Pre-loaded syringes with COVID-19 vaccine are ready for use in New Orleans, on Jan. 25, 2022. The COVID-19 vaccines are on track for a big recipe change this fall. Scientific advisers for the Food and Drug Administration on Thursday, June 15, 2023, discussed whether the next round of shots should only include protection against the newest omicron strains that are now dominant worldwide. (AP Photo/Ted Jackson, File)

FDA advisers consider changing COVID vaccine to target latest omicron strain

By Lauran Neergaard and Mike Stobbe - Associated Press

A nurse administers a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. U.S. regulators on Tuesday, April 18, 2023, cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else.(AP Photo/Rogelio V. Solis)

Extra spring COVID-19 booster cleared for certain Americans

By Lauran Neergaard - Associated Press

A sign marks an entrance to a Moderna building in Cambridge, Mass., on Monday, May 18, 2020. Moderna shares slipped Tuesday, April 11, 2023, after the COVID-19 vaccine developer said its potential flu vaccine needs more study in a late-stage clinical trial. (AP Photo/Bill Sikes) **FILE**

Moderna, Merck say vaccine-drug combo shows promise against melanoma

By Tom Howell Jr. - The Washington Times

Moderna CEO and Director Stephane Bancel arrives to testify to the Senate HELP Committee on the price of COVID-19 vaccine, Wednesday, March 22, 2023, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)

Moderna CEO defends COVID vaccine price hike, citing pivot to endemic phase

By Tom Howell Jr. - The Washington Times

A Jackson-Hinds Comprehensive Health Center nurse loads a syringe with a Moderna COVID-19 booster vaccine at an inoculation station next to Jackson State University in Jackson, Miss., Friday, Nov. 18, 2022. Moderna recently announced early evidence that its updated booster induced BQ.1.1-neutralizing antibodies. (AP Photo/Rogelio V. Solis)

Vaccine makers pick Senate fight over soaring prices; fall boosters cost up to $130

By Tom Howell Jr. and Haris Alic - The Washington Times

Syringes with vaccines are prepared at the L.A. Care and Blue Shield of California Promise Health Plans' Community Resource Center where they were offering members and the public free flu and COVID-19 vaccines Friday, Oct. 28, 2022, in Lynwood, Calif. The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot, a major shift in strategy despite a long list of questions about how to best protect against a still rapidly mutating virus.The Food and Drug Administration asked its scientific advisers Thursday, Jan. 26, 2023, to help lay the groundwork for switching to once-a-year boosters for most Americans -- and how and when to periodically update the shots’ recipe. (AP Photo/Mark J. Terrill)

FDA’s advisers back plan to simplify COVID-19 vaccinations

By Lauran Neergaard - Associated Press

Illustration on COVID-19 restrictions, courts and patents by Linas Garsys/The Washington Times

Next COVID-19 battle will be waged in court

By Gregory Dolin